THE CURE IS IN THE MESSAGE
Merlin Biotech applies proven mRNA technology for the development of novel therapeutics
Merlin Biotech is developing novel treatments using the clinically-proven mRNA platform. Our company is founded on the vision of bringing new therapies to diseases where few exist.
View our pipeline
mRNA TREATS A WIDE RANGE OF DISEASES
Here at Merlin, we view mRNA as the ultimate tool. Our goal is to harness the potential of the mRNA platform to treat a wide range of diseases.
Our lead program MER-101
The active ingredient in MER-101 is our proprietary mRNA encoding the naturally occurring protein USP6. Cancer insidiously avoids detection by the body's immune system and MER-101 is being developed to take the cloak off of cancer by activating multiple immunostimulatory pathways simultaneously. We are developing MER-101 for adult solid cancers as well as the rare childhood cancer known as Ewing sarcoma.
